Yeah, a few comments:
1. $100 / share; I'm not sure what type of angel dust you inhale, but happy to send my address. Leo would be orgasmic to sell the entire company for $500 million.
2. Today they released their 41st or 48th PR + shareholder alerts, and they also added an entirely new legal disclaimer that seems to really increase their own paranoia of what they are doing. Shouldn't they just keep their traps shut until the topline is released? It's rather sad. I also enjoyed the lines about "heading towards completion and topline data"; no one doubts this, but we know that is in July with topline the first few weeks of August, to provide for adequate time to spin their topline PR.
3. How many times has cancer been cured in rats and mice? It's an age old joke in pharma. Leave the petri dishes alone, shut the F up with the pumping on covid, let your topline speak for itself (good or bad), and why not discuss another program like GI or Oral Muc or Kevetrin--to at least give us hope that IF the covid trial bombs we won't bomb with you...
the desperation to keep their narrative alive (i'm sure they thought they'd be at a dollar per share by now, as they drift to .09 (Lemoncat's own share price call out)--and here they go...
News 
Market Data 
Discover 
